4//SEC Filing
Galligan Andrew H 4
Accession 0001567619-20-005412
CIK 0001444380other
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 2:48 PM ET
Size
6.6 KB
Accession
0001567619-20-005412
Insider Transaction Report
Form 4
NEVRO CORPNVRO
Galligan Andrew H
VP of Finance , CFO
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2020-02-28−8,000→ 33,394 totalExercise: $3.60Exp: 2021-09-28→ Common Stock (8,000 underlying) - Exercise/Conversion
Common Stock
2020-02-28$3.60/sh+8,000$28,800→ 61,490 total
Footnotes (2)
- [F1]Includes 16,773 restricted stock units.
- [F2]Fully vested.
Documents
Issuer
NEVRO CORP
CIK 0001444380
Entity typeother
Related Parties
1- filerCIK 0001417976
Filing Metadata
- Form type
- 4
- Filed
- Mar 2, 7:00 PM ET
- Accepted
- Mar 3, 2:48 PM ET
- Size
- 6.6 KB